Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Bristol-Myers Squibb
>
Warning: Andrew Coop
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 5245002"]It has come to our attention that AstraZeneca's Sr. Management have extended an offer to Mr. Andrew Coop to head an Oncology Medical Affairs Sr. Leadership position. This desparate move is despite Andrew Coop nasty track records at his former job BMS which caused his demotion from Head of Oncology Global Medical Affairs to Data Mining supervisory capacity. During his tenure at BMS many highly qualified individuals left the company due to his lack of leadership and management. After an investigation, it was found that he had lied and bullied his way during his tenure at BMS and was one of the main reasons for Yervoy as well as other programs slow start and growth. </p><p>Now, despite having a non-compete section in his contract with BMS, he has copied all BMS sensitive development and marketing information and is about to hand them over to AstraZeneca and his new team.</p><p>BMS legal team has been informed and we have requested a follow up and possible legal action against Andrew Coop and or AstraZeneca.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 5245002"]It has come to our attention that AstraZeneca's Sr. Management have extended an offer to Mr. Andrew Coop to head an Oncology Medical Affairs Sr. Leadership position. This desparate move is despite Andrew Coop nasty track records at his former job BMS which caused his demotion from Head of Oncology Global Medical Affairs to Data Mining supervisory capacity. During his tenure at BMS many highly qualified individuals left the company due to his lack of leadership and management. After an investigation, it was found that he had lied and bullied his way during his tenure at BMS and was one of the main reasons for Yervoy as well as other programs slow start and growth. Now, despite having a non-compete section in his contract with BMS, he has copied all BMS sensitive development and marketing information and is about to hand them over to AstraZeneca and his new team. BMS legal team has been informed and we have requested a follow up and possible legal action against Andrew Coop and or AstraZeneca.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Bristol-Myers Squibb
>
Warning: Andrew Coop
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Bristol-Myers Squibb
>
Warning: Andrew Coop
>